1. Immunology/Inflammation
  2. Tim3
  3. ML-T7

ML-T7 是一种有效的 Tim-3 抑制剂。ML-T7 阻断 Tim-3 与 PtdSer 和 CEACAM1 的相互作用。ML-T7 不仅增强 CTLs 和 CAR T 细胞过继转移治疗的抗肿瘤活性,而且还增强 T 细胞的效应功能。ML-T7 促进 NK 细胞对肿瘤细胞的杀伤活性和 DC 抗原呈递能力。ML-T7 单独使用或与 Nivolumab (HY-P9903A) 联合使用可在临床前肿瘤模型中直接发挥抗肿瘤功效。ML-T7 可用于肿瘤免疫治疗研究。

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

ML-T7 Chemical Structure

ML-T7 Chemical Structure

CAS No. : 459789-75-4

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

规格 价格 是否有货 数量
5 mg ¥1480
In-stock
10 mg ¥2250
In-stock
25 mg ¥4500
In-stock
50 mg ¥6666
In-stock
100 mg ¥10000
In-stock
200 mg   询价  
500 mg   询价  

* Please select Quantity before adding items.

Customer Review

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

ML-T7 is a potent Tim-3 inhibitor. ML-T7 blocks Tim-3 interactions with PtdSer and CEACAM1. ML-T7 not only enhances the antitumor activity of adoptive transfer therapy with cytotoxic T lymphocytes (CTLs) and CAR T cells but also increases the effector function of T cell. ML-T7 promotes NK cells’ killing activity against tumor cells and DC antigen-presenting capacity. ML-T7 directly exerts antitumor efficacy in preclinical tumor models either alone or in combination with Nivolumab (HY-P9903A). ML-T7 can be used for tumor immunotherapy research[1].

体外研究
(In Vitro)

ML-T7(10 μM, 0-6 days) 通过Tim-3增强TCR/STAT5信号通路,促进CD8+细胞抗肿瘤活性[1]
ML-T7(10 μM, 24 h) 可通过Tim-3和Tim-4促进DC的成熟和功能,增强DC抗原呈递能力[1]
ML-T7(10 μM, 24 h) 增强CTL激活和细胞因子产生,减少CTLs的凋亡[1]
ML-T7(10 μM, 48 h) 可显著增强人NK 细胞系NK92细胞中IFN-γ、TNF-α、CD107a 和granzyme B的产生[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Western Blot Analysis[1]

Cell Line: CD8+ cell
Concentration: 10 μM
Incubation Time: 0-6 days
Result: Increased the phosphorylation of phospholipase C–γ1(PLC-γ1), ZAP70, LCK, ERK1/2, and STAT5 upon anti-CD3/CD28 stimulation.

Cell Invasion Assay[1]

Cell Line: Bone Marrow Cells
Concentration: 10 μM
Incubation Time: 24 h
Result: Increased the expression of DC maturation markers.
体内研究
(In Vivo)

ML-T7 (10-50 mg/kg; 腹腔注射; every 2 days, 10 times) 抑制肿瘤生长并延长小鼠的生存期,对小鼠体重无不良影响[1]
ML-T7 (20 mg/kg; 腹腔注射; every 2 days, 10 times)和 Nivolumab (HY-P9903A)联合治疗可提升 Nivolumab (HY-P9903A)抗体的抗肿瘤效果,同时可有效提高HCC小鼠存活率[1]
ML-T7 (50 mg/kg, 腹腔注射; every 2 days for 3 weeks)在小鼠中表现出良好的安全性[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: 10-week-old mice with spontaneous orthotopic HCC[1]
Dosage: 10-50 mg/kg
Administration: Intraperitoneal injection (i.p.), every 2 days, 10 times
Result: Increased CD8+ T cells in both tumor and spleen. Inhibited T cell exhaustion. Promoted the function of CTLs, NK cells, and DCs.
Animal Model: 10-week-old mice with orthotopic Akt/c-Myc HCC[1]
Dosage: 20 mg/kg
Administration: Intraperitoneal injection (i.p.), every 2 days, 10 times
Result: Indicated stronger antituomr activity when treated with ML-T7 and Nivolumab (HY-P9903A). Rejuvenated NK cells by the combination therapy. Inhibited the accumulation of MDSCs and Tregs.
分子量

506.33

Formula

C27H17Cl2NO5

CAS 号
性状

固体

颜色

White to off-white

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式
Powder -20°C 3 years
4°C 2 years
In solvent -80°C 6 months
-20°C 1 month
溶解性数据
In Vitro: 

DMSO 中的溶解度 : 69.5 mg/mL (137.26 mM; 超声助溶 (<60°C); 吸湿的 DMSO 对产品的溶解度有显著影响,请使用新开封的 DMSO)

配制储备液
浓度 溶剂体积 质量 1 mg 5 mg 10 mg
1 mM 1.9750 mL 9.8750 mL 19.7500 mL
5 mM 0.3950 mL 1.9750 mL 3.9500 mL
查看完整储备液配制表

* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效
储备液的保存方式和期限:-80°C, 6 months; -20°C, 1 month。-80°C储存时,请在6个月内使用,-20°C储存时,请在1个月内使用。

  • 摩尔计算器

  • 稀释计算器

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量
=
浓度
×
体积
×
分子量 *

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start)

C1

×
体积 (start)

V1

=
浓度 (final)

C2

×
体积 (final)

V2

动物溶解方案计算器
请输入动物实验的基本信息:

给药剂量

mg/kg

动物的平均体重

g

每只动物的给药体积

μL

动物数量

由于实验过程有损耗,建议您多配一只动物的量
计算结果
工作液所需浓度 : mg/mL
纯度 & 产品资料
参考文献

ML-T7 相关分类

完整储备液配制表

* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效
储备液的保存方式和期限:-80°C, 6 months; -20°C, 1 month。-80°C储存时,请在6个月内使用,-20°C储存时,请在1个月内使用。

可选溶剂 浓度 溶剂体积 质量 1 mg 5 mg 10 mg 25 mg
DMSO 1 mM 1.9750 mL 9.8750 mL 19.7500 mL 49.3749 mL
5 mM 0.3950 mL 1.9750 mL 3.9500 mL 9.8750 mL
10 mM 0.1975 mL 0.9875 mL 1.9750 mL 4.9375 mL
15 mM 0.1317 mL 0.6583 mL 1.3167 mL 3.2917 mL
20 mM 0.0987 mL 0.4937 mL 0.9875 mL 2.4687 mL
25 mM 0.0790 mL 0.3950 mL 0.7900 mL 1.9750 mL
30 mM 0.0658 mL 0.3292 mL 0.6583 mL 1.6458 mL
40 mM 0.0494 mL 0.2469 mL 0.4937 mL 1.2344 mL
50 mM 0.0395 mL 0.1975 mL 0.3950 mL 0.9875 mL
60 mM 0.0329 mL 0.1646 mL 0.3292 mL 0.8229 mL
80 mM 0.0247 mL 0.1234 mL 0.2469 mL 0.6172 mL
100 mM 0.0197 mL 0.0987 mL 0.1975 mL 0.4937 mL
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称:

 

* 需求量:

* 客户姓名:

 

* Email:

* 电话:

 

* 公司或机构名称:

   留言给我们:

Bulk Inquiry

Inquiry Information

产品名称:
ML-T7
目录号:
HY-163028
需求量: